These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22010784)

  • 21. Biomarker for early renal microvascular and diabetic kidney diseases.
    Futrakul N; Futrakul P
    Ren Fail; 2017 Nov; 39(1):505-511. PubMed ID: 28494191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal autoregulation and passive pressure-flow relationships in diabetes and hypertension.
    Hill JV; Findon G; Appelhoff RJ; Endre ZH
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F837-44. PubMed ID: 20660017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic.
    Al-Wakeel JS; Hammad D; Al Suwaida A; Mitwalli AH; Memon NA; Sulimani F
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):77-85. PubMed ID: 19112222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
    Song J; Meng L; Li S; Qu L; Li X
    Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A biomarker for detecting early tubulointerstitial disease and ischemia in glomerulonephropathy.
    Deekajorndech T
    Ren Fail; 2007; 29(8):1013-7. PubMed ID: 18067049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
    Jones C; Roderick P; Harris S; Rogerson M
    Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered vascular homeostasis in chronic kidney disease.
    Futrakul N; Butthep P; Futrakul P
    Clin Hemorheol Microcirc; 2008; 38(3):201-7. PubMed ID: 18239262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural history of chronic allograft nephropathy.
    Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Allen RD; Chapman JR
    N Engl J Med; 2003 Dec; 349(24):2326-33. PubMed ID: 14668458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diabetic nephropathy. I].
    Serban V; Băcanu GS; Serban M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(3):209-20. PubMed ID: 2573930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of renal function in type 2 diabetic nephropathy.
    Futrakul N; Butthep P; Futrakul P; Sitprija V
    Ren Fail; 2007; 29(2):155-8. PubMed ID: 17365929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design.
    Shikata K; Haneda M; Koya D; Suzuki Y; Tomino Y; Yamada K; Maeda S; Kawakami N; Uzu T; Nishimura M; Sato C; Ogawa D; Makino H;
    Diabetes Res Clin Pract; 2010 Feb; 87(2):228-32. PubMed ID: 19889469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.
    Lindenmeyer MT; Kretzler M; Boucherot A; Berra S; Yasuda Y; Henger A; Eichinger F; Gaiser S; Schmid H; Rastaldi MP; Schrier RW; Schlöndorff D; Cohen CD
    J Am Soc Nephrol; 2007 Jun; 18(6):1765-76. PubMed ID: 17475821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal protection in diabetes: role of glycemic control.
    Fioretto P; Bruseghin M; Berto I; Gallina P; Manzato E; Mussap M
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S86-9. PubMed ID: 16565255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic diabetic nephropathy: role of inducible nitric oxide synthase.
    Trachtman H; Futterweit S; Pine E; Mann J; Valderrama E
    Pediatr Nephrol; 2002 Jan; 17(1):20-9. PubMed ID: 11793130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases.
    Zhou J; Chen X; Xie Y; Li J; Yamanaka N; Tong X
    Nephrol Dial Transplant; 2008 Jun; 23(6):1940-5. PubMed ID: 18156459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical considerations concerning progressive diabetic renal diseases. Severe complications of early onset diabetes mellitus.
    Corniţescu G; Moţa M; Moţa E; Stănescu L
    Rom J Intern Med; 2003; 41(1):53-60. PubMed ID: 15529585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adequate vascular repair is relevant to improving renal perfusion and function following vasodilators in normoalbuminuric type 2 diabetic nephropathy.
    Futrakul N; Futrakul P
    Am J Kidney Dis; 2009 Sep; 54(3):583-4. PubMed ID: 19700066
    [No Abstract]   [Full Text] [Related]  

  • 39. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Specific elements of diagnosis in diabetic nephropathy].
    Mihai B; Lăcătuşu C; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):329-37. PubMed ID: 17983164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.